Related Experiment Video
Updated: Jul 4, 2026
08:25
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
Published on: September 26, 2022
Impaired initiation of contact hypersensitivity by FTY720
Daiki Nakashima1, Kenji Kabashima, Jun-Ichi Sakabe
1Department of Dermatology, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Japan.
The Journal of Investigative Dermatology
|July 4, 2008
Summary
FTY720, a sphingosine-1-phosphate receptor 1 (S1P1) modulator, impairs T-cell mediated contact hypersensitivity (CHS) by preventing naive T-cell recirculation. This drug reduces T-cell sensitization, crucial for immune responses.
Area of Science:
- Immunology
- Pharmacology
Background:
- Sphingosine-1-phosphate (S1P) signaling regulates lymphocyte trafficking.
- FTY720 is an S1P receptor modulator with known effects on lymphocyte emigration.
Purpose of the Study:
- To investigate the impact of FTY720 on murine contact hypersensitivity (CHS).
- To elucidate the role of S1P-S1P1 signaling in naive T-cell recirculation and immune sensitization.
Main Methods:
- Murine model of contact hypersensitivity (CHS).
- Administration of FTY720 during sensitization and elicitation phases.
- Adoptive transfer of T cells.
- Flow cytometry analysis of T-cell subsets (CD44, CD62L).
- Assessment of S1P receptor 1 (S1P1) mRNA expression.
Main Results:
- FTY720 significantly impaired CHS when given during sensitization, but not elicitation.
- Adoptive transfer of FTY720-treated cells failed to induce CHS.
- FTY720 reduced naive T cells more than memory T cells.
- Naive T cells showed higher S1P1 expression and chemotaxis compared to memory T cells.
Conclusions:
- S1P-S1P1 signaling is critical for naive T-cell recirculation.
- FTY720 disrupts T-cell sensitization by inhibiting naive T-cell trafficking to lymph nodes.
- FTY720's effects on CHS are mediated by its impact on naive T-cell homing and interaction with antigen-presenting cells.
Related Concept Videos
01:29Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:30Hypersensitivities
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
01:01Hypersensitivity Reactions: Cytolytic Reactions
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...